Results 151 to 160 of about 145,853 (310)

Validity of a Portable Breath Analyser (AIRE) for the Assessment of Lactose Malabsorption [PDF]

open access: gold, 2019
Aahana Shrestha   +6 more
openalex   +1 more source

Tuberculosis‐Associated Paradoxical Immune Reconstitution Inflammatory Syndrome in an HIV‐Negative Patient Presenting With a Recurrent Pleural Effusion Managed With Prednisolone: A Case Report

open access: yesClinical Case Reports, Volume 14, Issue 1, January 2026.
Chest CT scan 1 month after starting TB treatment demonstarting left side massive pleural effusion. ABSTRACT Non‐HIV‐infected people with pulmonary tuberculosis can develop paradoxical worsening of lung conditions, including massive pleural effusion, which at times requires multiple drainage. This paradoxical immune reconstitution inflammatory syndrome
Selam Bogale Gissa   +2 more
wiley   +1 more source

Pharmacokinetics and Safety of Single‐Dose Apraglutide in Individuals with Normal and Impaired Hepatic Function: A Phase 1, Open‐Label Trial

open access: yesClinical Pharmacology in Drug Development, Volume 15, Issue 1, January 2026.
Abstract Intestinal failure‐associated liver disease occurs in 20% to 30% of patients with short bowel syndrome and intestinal failure (SBS‐IF). Apraglutide is a glucagon‐like peptide‐2 (GLP‐2) analog in clinical development for the treatment of patients with SBS‐IF.
Gerard Greig   +4 more
wiley   +1 more source

Best of United European Gastroenterology Week 2025

open access: yes
United European Gastroenterology Journal, Volume 14, Issue 1, February 2026.
Iuliana Nenu   +3 more
wiley   +1 more source

Quantitative Systems Toxicology Predicts Ivacaftor‐Induced Oxidative Stress Contributes to CFTR Modulator Hepatotoxicity

open access: yesClinical Pharmacology &Therapeutics, Volume 119, Issue 1, Page 208-218, January 2026.
Cystic fibrosis (CF) is a chronic hereditary disease that affects tens of thousands of people worldwide. The introduction of CFTR modulator therapies such as elexacaftor/tezacaftor/ivacaftor (ETI) has significantly improved the quality of life of people with CF.
Alan Shi   +3 more
wiley   +1 more source

Type 1 Diabetes and Other Autoimmune Diseases—Epidemiology, Pathophysiology and Screening

open access: yesEndocrinology, Diabetes &Metabolism, Volume 9, Issue 1, January 2026.
Individuals with type 1 diabetes exhibit significantly increased prevalence of additional autoimmune diseases. Epidemiological, familial and mechanistic evidence indicates frequent polyautoimmunity and shared genetic and environmental drivers. Coexistence complicates clinical management, and autoantibody‐based detection often identifies preclinical ...
George J. Kahaly   +6 more
wiley   +1 more source

A Systematic Review of Quality of Life in Patients with Short Bowel Syndrome and Their Caregivers

open access: yesPatient Preference and Adherence
Ying Chen,1 Mengxia Yan,1 Haoyan Chen,1 Yanan Sheng,2 Zhenhua Wang,3 Bin Wu1 1Clinical Research Institute, Ren Ji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, 201112, People’s Republic of China; 2Medical Affairs, Takeda (China ...
Chen Y   +5 more
doaj  

Prevalence of Fructose Malabsorption in Patients With Irritable Bowel Syndrome After Excluding Small Intestinal Bacterial Overgrowth

open access: diamond, 2018
Kee Wook Jung   +17 more
openalex   +2 more sources

Home - About - Disclaimer - Privacy